1575 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients
Condition: Lymphoproliferative Disorders
Intervention: Other: Determining the source of EBV in severe EBV infections
22 Not yet recruiting Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: Brentuximab Vedotin;   Drug: Adriamycin;   Drug: Dacarbazine
23 Not yet recruiting Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)
Condition: Lymphoma
24 Recruiting Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Conditions: Solid Tumors;   Lymphoma
Intervention: Drug: ASTX660
25 Not yet recruiting A Study of HMPL-523 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas or Chronic Lymphocytic Leukemia
Conditions: B-cell Non-Hodgkin's Lymphomas;   Chronic Lymphocytic Leukemia
Intervention: Drug: HMPL-523
26 Recruiting Study of Intratumoral G100 Therapy in Patients With Follicular Non-Hodgkin's Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: G100
27 Not yet recruiting Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome
Intervention: Biological: ATIR101
28 Not yet recruiting A Safety and Pharmacokinetic Study of BTCT4465A in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Condition: Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin
Intervention: Drug: BTCT4465A
29 Not yet recruiting GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: Obinutuzumab and Pixantrone
30 Recruiting Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete Response
Condition: Central Nervous System Lymphoma
Interventions: Biological: Obinutuzumab;   Other: Quality-of-Life Assessment
31 Not yet recruiting Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Cytokine-induced killer cells (CIK)
32 Recruiting Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples
Conditions: Lymphadenopathy;   Tuberculosis;   Sarcoidosis
Interventions: Device: Nested PCR for formalin-fixed tissues;   Device: Nested PCR for fresh tissues;   Device: Real-time PCR for fresh tissues
33 Recruiting Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
Conditions: Arteriovenous Malformation;   Hemangioma;   Neoplasms Lymph Nodes;   Lymphedema
Intervention: Drug: 68Ga-NEB
34 Not yet recruiting Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
Condition: Peripheral T-cell Lymphoma
Intervention: Drug: Fenretinide
35 Recruiting Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Ruxolitinib;   Drug: Dasatinib;   Drug: Dexamethasone
36 Recruiting Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma
Condition: Lymphoma
Intervention: Radiation: Radiation Therapy
37 Recruiting Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)
Conditions: Breast Cancer;   Upper Extremity Lymphedema
Intervention: Drug: QBX258
38 Not yet recruiting Comfort Subcutaneous Drainage: a Descriptive Study Among Palliative Phase Cancer Patients
Condition: Lymphedema
Intervention: Procedure: subcutaneous drainage
39 Not yet recruiting Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Bendamustine + Rituximab
40 Recruiting Study of the Angiogenesis by PET/CT in Patients With Diffuse Large B Cells Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Intervention: Device: RGD K5 PET scan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years